Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Corporate Action | 30 June 2025 (4 announcements)

Apollo Hospitals announced a composite scheme of arrangement involving the demerger of its omni-channel pharmacy and digital health businesses into a new listed entity, Apollo Healthtech Limited, alongside the amalgamation of two transferor companies into the same entity. Shareholders will receive 195.2 new shares per 100 existing shares, creating India's largest integrated healthcare platform with FY25 revenue of INR 16,300 crores targeting INR 25,000 crores by FY27. The transaction, approved by the Board on June 30, 2025, requires regulatory clearances including NCLT and SEBI, and includes a 15% retained stake for Apollo Hospitals with a nominee director on the new board.

Apollo Hospitals announced a composite scheme of arrangement involving the demerger of its omni-channel pharmacy and digital health businesses into a new listed entity, Apollo Healthtech Limited, alongside the amalgamation of two transferor companies into the same entity. Shareholders will receive 195.2 NewCo shares for every 100 AHEL shares, enabling direct ownership in the combined platform. The transaction, approved by the Board on June 30, 2025, targets INR 25,000 crores revenue by FY27 from a FY25 base of INR 16,300 crores, with a 7% EBITDA margin target. Listing is planned within 18-21 months, and Apollo Healthco will retain a 15% stake. The scheme, structured as a related-party transaction with arm's length fairness validation by Axis Capital, eliminates holdco discount and integrates digital health services across 73 hospitals, 6,000 pharmacies, and 33 million user base.

Apollo Hospitals Enterprise Limited announced a Composite Scheme of Arrangement to reorganize its Omni Channel Pharmacy and Digital Health businesses, unlocking value for shareholders. The proposal involves restructuring these units into a separate entity, aiming to enhance focus and operational efficiency. The company scheduled a conference call for July 1, 2025, at 12 noon IST to discuss the scheme, with key executives presenting. Shareholders will benefit from a more streamlined business structure, though specific financial metrics were not disclosed in the filing.

Apollo Hospitals announced a composite scheme of arrangement to merge its digital health and pharmacy units with Keimed into a new listed entity, offering shareholders 195.2 NewCo shares per existing share and targeting a combined revenue of INR 25k crores by FY27. The transaction involves demerger, merger, and share consolidation steps requiring shareholder and NCLT approvals, with listing expected within 18-21 months.